COULD COVID-19 TRIGGER TYPE 1 DIABETES? PRESENTATION OF COVID-19 CASE PRESENTED WITH DIABETIC KETOACIDOSIS
COVID-19 is a viral disease that is recognized now as a pandemic by the World Health Organization. It is known that some viral infections may trigger autoimmune diseases. It has been revealed that COVID-19 may also lead to the pathogenesis of some autoimmune diseases, including Type 1 DM (T1DM) and...
Gespeichert in:
Veröffentlicht in: | Acta endocrinologica (Bucharest, Romania : 2005) Romania : 2005), 2021-10, Vol.17 (4), p.532-536 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 536 |
---|---|
container_issue | 4 |
container_start_page | 532 |
container_title | Acta endocrinologica (Bucharest, Romania : 2005) |
container_volume | 17 |
creator | Genç, S Evren, B Bozbay, A Aydın, E Ş Genç, Ö Şahin, I |
description | COVID-19 is a viral disease that is recognized now as a pandemic by the World Health Organization. It is known that some viral infections may trigger autoimmune diseases. It has been revealed that COVID-19 may also lead to the pathogenesis of some autoimmune diseases, including Type 1 DM (T1DM) and autoimmune thyroid diseases. Here, we aimed to present a young female patient with COVID-19, who we followed up in our clinic, who presented with diabetic ketoacidosis (DKA), and developed Hashimoto's disease during the treatment process. In order to emphasize that COVID-19 may trigger the emergence of T1DM, that it may mask nonspecific DKA symptoms like nausea and vomiting, that it may cause delay in diagnosis of DKA, and also to emphasize the importance of evaluating other autoimmune diseases accompanying COVID-19, we found it appropriate to present this case. |
doi_str_mv | 10.4183/aeb.2021.532 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9206149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2681043311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-79a9d76604d290b67f930527a5ed9856181271539ed3962465b2f07b357c13fb3</originalsourceid><addsrcrecordid>eNpVkc1P20AQxVdVUaG0t57RHnvAYWfX-3UBGXsJq0YYxQbKaeWPNQQlMbUTJP57DAQKpxlp3nszox9Cv4CMQlDsoPDliBIKI87oF7QDKmQBEeLv15ceAqKV3Ebf-_6OEK4IwDe0zbgMpeJqB93F6cUkwXF6aZMANM6ndjw2U5xfnxsMOLHRsclNdoTPpyYzZ3mU2_QMpyf_HXGUmbepSfCVzU83NhvjPyZPo9gmaWazH2irKea9_7mpu-jixOTxaTBJxzaOJkHFVLgKpC50LYUgYU01KYVsNCOcyoL7WisuQAGVwJn2NdOChoKXtCGyHH6qgDUl20WHr7n363Lh68ovV10xd_fdbFF0j64tZu7zZDm7dTftg9OUCAj1EPB7E9C1_9a-X7nFrK_8fF4sfbvuHRUKSMgYwCDdf5VWXdv3nW_e1wBxz3jcgMc943EDnkG-9_G0d_EbD_YEznuBAA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2681043311</pqid></control><display><type>article</type><title>COULD COVID-19 TRIGGER TYPE 1 DIABETES? PRESENTATION OF COVID-19 CASE PRESENTED WITH DIABETIC KETOACIDOSIS</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Genç, S ; Evren, B ; Bozbay, A ; Aydın, E Ş ; Genç, Ö ; Şahin, I</creator><creatorcontrib>Genç, S ; Evren, B ; Bozbay, A ; Aydın, E Ş ; Genç, Ö ; Şahin, I</creatorcontrib><description>COVID-19 is a viral disease that is recognized now as a pandemic by the World Health Organization. It is known that some viral infections may trigger autoimmune diseases. It has been revealed that COVID-19 may also lead to the pathogenesis of some autoimmune diseases, including Type 1 DM (T1DM) and autoimmune thyroid diseases. Here, we aimed to present a young female patient with COVID-19, who we followed up in our clinic, who presented with diabetic ketoacidosis (DKA), and developed Hashimoto's disease during the treatment process. In order to emphasize that COVID-19 may trigger the emergence of T1DM, that it may mask nonspecific DKA symptoms like nausea and vomiting, that it may cause delay in diagnosis of DKA, and also to emphasize the importance of evaluating other autoimmune diseases accompanying COVID-19, we found it appropriate to present this case.</description><identifier>ISSN: 1841-0987</identifier><identifier>EISSN: 1843-066X</identifier><identifier>DOI: 10.4183/aeb.2021.532</identifier><identifier>PMID: 35747858</identifier><language>eng</language><publisher>Romania: Carol Davila University Press</publisher><subject>Case Report</subject><ispartof>Acta endocrinologica (Bucharest, Romania : 2005), 2021-10, Vol.17 (4), p.532-536</ispartof><rights>2021 Acta Endocrinologica (Buc).</rights><rights>2021 Acta Endocrinologica (Buc) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-79a9d76604d290b67f930527a5ed9856181271539ed3962465b2f07b357c13fb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206149/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206149/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35747858$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Genç, S</creatorcontrib><creatorcontrib>Evren, B</creatorcontrib><creatorcontrib>Bozbay, A</creatorcontrib><creatorcontrib>Aydın, E Ş</creatorcontrib><creatorcontrib>Genç, Ö</creatorcontrib><creatorcontrib>Şahin, I</creatorcontrib><title>COULD COVID-19 TRIGGER TYPE 1 DIABETES? PRESENTATION OF COVID-19 CASE PRESENTED WITH DIABETIC KETOACIDOSIS</title><title>Acta endocrinologica (Bucharest, Romania : 2005)</title><addtitle>Acta Endocrinol (Buchar)</addtitle><description>COVID-19 is a viral disease that is recognized now as a pandemic by the World Health Organization. It is known that some viral infections may trigger autoimmune diseases. It has been revealed that COVID-19 may also lead to the pathogenesis of some autoimmune diseases, including Type 1 DM (T1DM) and autoimmune thyroid diseases. Here, we aimed to present a young female patient with COVID-19, who we followed up in our clinic, who presented with diabetic ketoacidosis (DKA), and developed Hashimoto's disease during the treatment process. In order to emphasize that COVID-19 may trigger the emergence of T1DM, that it may mask nonspecific DKA symptoms like nausea and vomiting, that it may cause delay in diagnosis of DKA, and also to emphasize the importance of evaluating other autoimmune diseases accompanying COVID-19, we found it appropriate to present this case.</description><subject>Case Report</subject><issn>1841-0987</issn><issn>1843-066X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkc1P20AQxVdVUaG0t57RHnvAYWfX-3UBGXsJq0YYxQbKaeWPNQQlMbUTJP57DAQKpxlp3nszox9Cv4CMQlDsoPDliBIKI87oF7QDKmQBEeLv15ceAqKV3Ebf-_6OEK4IwDe0zbgMpeJqB93F6cUkwXF6aZMANM6ndjw2U5xfnxsMOLHRsclNdoTPpyYzZ3mU2_QMpyf_HXGUmbepSfCVzU83NhvjPyZPo9gmaWazH2irKea9_7mpu-jixOTxaTBJxzaOJkHFVLgKpC50LYUgYU01KYVsNCOcyoL7WisuQAGVwJn2NdOChoKXtCGyHH6qgDUl20WHr7n363Lh68ovV10xd_fdbFF0j64tZu7zZDm7dTftg9OUCAj1EPB7E9C1_9a-X7nFrK_8fF4sfbvuHRUKSMgYwCDdf5VWXdv3nW_e1wBxz3jcgMc943EDnkG-9_G0d_EbD_YEznuBAA</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Genç, S</creator><creator>Evren, B</creator><creator>Bozbay, A</creator><creator>Aydın, E Ş</creator><creator>Genç, Ö</creator><creator>Şahin, I</creator><general>Carol Davila University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211001</creationdate><title>COULD COVID-19 TRIGGER TYPE 1 DIABETES? PRESENTATION OF COVID-19 CASE PRESENTED WITH DIABETIC KETOACIDOSIS</title><author>Genç, S ; Evren, B ; Bozbay, A ; Aydın, E Ş ; Genç, Ö ; Şahin, I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-79a9d76604d290b67f930527a5ed9856181271539ed3962465b2f07b357c13fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Case Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Genç, S</creatorcontrib><creatorcontrib>Evren, B</creatorcontrib><creatorcontrib>Bozbay, A</creatorcontrib><creatorcontrib>Aydın, E Ş</creatorcontrib><creatorcontrib>Genç, Ö</creatorcontrib><creatorcontrib>Şahin, I</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta endocrinologica (Bucharest, Romania : 2005)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Genç, S</au><au>Evren, B</au><au>Bozbay, A</au><au>Aydın, E Ş</au><au>Genç, Ö</au><au>Şahin, I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COULD COVID-19 TRIGGER TYPE 1 DIABETES? PRESENTATION OF COVID-19 CASE PRESENTED WITH DIABETIC KETOACIDOSIS</atitle><jtitle>Acta endocrinologica (Bucharest, Romania : 2005)</jtitle><addtitle>Acta Endocrinol (Buchar)</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>17</volume><issue>4</issue><spage>532</spage><epage>536</epage><pages>532-536</pages><issn>1841-0987</issn><eissn>1843-066X</eissn><abstract>COVID-19 is a viral disease that is recognized now as a pandemic by the World Health Organization. It is known that some viral infections may trigger autoimmune diseases. It has been revealed that COVID-19 may also lead to the pathogenesis of some autoimmune diseases, including Type 1 DM (T1DM) and autoimmune thyroid diseases. Here, we aimed to present a young female patient with COVID-19, who we followed up in our clinic, who presented with diabetic ketoacidosis (DKA), and developed Hashimoto's disease during the treatment process. In order to emphasize that COVID-19 may trigger the emergence of T1DM, that it may mask nonspecific DKA symptoms like nausea and vomiting, that it may cause delay in diagnosis of DKA, and also to emphasize the importance of evaluating other autoimmune diseases accompanying COVID-19, we found it appropriate to present this case.</abstract><cop>Romania</cop><pub>Carol Davila University Press</pub><pmid>35747858</pmid><doi>10.4183/aeb.2021.532</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1841-0987 |
ispartof | Acta endocrinologica (Bucharest, Romania : 2005), 2021-10, Vol.17 (4), p.532-536 |
issn | 1841-0987 1843-066X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9206149 |
source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Case Report |
title | COULD COVID-19 TRIGGER TYPE 1 DIABETES? PRESENTATION OF COVID-19 CASE PRESENTED WITH DIABETIC KETOACIDOSIS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T12%3A45%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COULD%20COVID-19%20TRIGGER%20TYPE%201%20DIABETES?%20PRESENTATION%20OF%20COVID-19%20CASE%20PRESENTED%20WITH%20DIABETIC%20KETOACIDOSIS&rft.jtitle=Acta%20endocrinologica%20(Bucharest,%20Romania%20:%202005)&rft.au=Gen%C3%A7,%20S&rft.date=2021-10-01&rft.volume=17&rft.issue=4&rft.spage=532&rft.epage=536&rft.pages=532-536&rft.issn=1841-0987&rft.eissn=1843-066X&rft_id=info:doi/10.4183/aeb.2021.532&rft_dat=%3Cproquest_pubme%3E2681043311%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2681043311&rft_id=info:pmid/35747858&rfr_iscdi=true |